×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Senolytic Safety and Efficacy in the Central Nervous System
therapeutic
1,340 words
KG: Senolytic Safety and Efficacy in the Central Nervous System
2026-03-25
kind:therapeutic
section:therapeutics
state:published
Contents
Senolytic Safety and Efficacy in the Central Nervous System
💊
Therapeutic Info
Name
Senolytic Safety and Efficacy in the Central Nervous System
Summary
Clinical evidence for senolytic therapy safety and efficacy in neurodegenerative diseases affecting the CNS
Knowledge Graph
Related Hypotheses (22)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Purinergic Signaling Polarization Control
Score: 0.55
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62
APOE-Dependent Autophagy Restoration
Score: 0.61
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Blood-Brain Barrier SPM Shuttle System
Score: 0.55
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Aquaporin-4 Polarization Rescue
Score: 0.51
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
APOE Isoform Conversion Therapy
Score: 0.44
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.44
Extracellular Matrix Stiffness Modulation
Score: 0.43
Show 17 more
Related Analyses (16)
Systemic immune profiling and peripheral immune contribution
neurodegeneration · completed
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed
Can IGFBPL1 therapeutics effectively cross the blood-brain b
drug delivery · failed
How can AQP4 be effectively targeted therapeutically to impr
neurodegeneration · failed
What are the specific molecular mechanisms by which AQP4 dys
neurodegeneration · failed
How can CNS-selective HDAC/DNMT inhibitors be developed to a
pharmacology · failed
Does CXCL10 inhibition compromise CNS immune surveillance du
neuroimmunology · failed
How can CRISPR systems achieve persistent therapeutic effect
gene therapy · failed
What determines blood-brain barrier penetration kinetics for
neuropharmacology · failed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed
Show 11 more
Related Experiments (2)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's
clinical · proposed · Score: 0.40
See Also (15)
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
WNK1 Kinase in Neurodegeneration
mechanism · Pages share 5 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 5 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 5 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 5 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 5 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 5 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 5 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 5 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 5 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 5 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 5 hypotheses
Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 5 hypotheses
synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 5 hypotheses
Show 10 more